T 1229/17 (Analysis of glatiramer acetate batches/MOMENTA) of 01.12.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T122917.20211201
- Date of decision
- 1 December 2021
- Case number
- T 1229/17
- Online on
- 17 March 2022
- Petition for review of
- -
- Application number
- 09733444.5
- IPC class
- C07K 14/00G01N 33/68
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- ANALYSIS OF AMINO ACID COPOLYMER COMPOSITIONS
- Applicant name
- Momenta Pharmaceuticals, Inc.
- Opponent name
- Actavis Group ehf
Guardian IP Consulting I/S
Generics [UK] Ltd (trading as Mylan) - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)European Patent Convention R 80European Patent Convention Art 84European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 56
- Keywords
- Late-filed evidence
Amendment occasioned by ground for opposition - (yes)
Claims - clarity (yes)
Amendments - allowable (yes) extension beyond the content of the patent (no)
Inventive step - (no) MR: effect not made credible within the whole scope of claim; (yes) AR1 - Catchword
- -
- Cited cases
- -
- Citing cases
- T 0309/17
Order
For these reasons it is decided that:
The appeals are dismissed.